Skip to content
MedsAcross

Medicine

Levetiracetam 750 mg extended-release tablet

Available on requestPrescription onlyUS FDAGeneric name

Levetiracetam 750 mg extended-release tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Levetiracetam
Brand
Sold under the generic name
Strength
750 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
60 tablets, 500 tablets, 120 tablets and 24 more
Manufacturers
Torrent PharmaceuticalsIndiaLupinIndiaProficient RxScieGen PharmaceuticalsApotexOmnivium PharmaceuticalsSolco HealthcareBluePoint LaboratoriesGolden State Medical SupplyRemedyrepack
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AX14 Levetiracetam
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 September 2011
Identifiers
RxCUI 807832, 846378, 1605362DailyMed set ID 7cb669d7-d1aa-43b3-a322-0a2eaa13c656, bc8644ed-3320-47b5-adf3-8b972bea8abd, 3e32f341-9926-47a3-a942-d8b9bfa7a55b +8NDC 13668-300, 43547-346, 50228-190 +8Application ANDA091338, ANDA203468, ANDA205130 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
60 tablet, extended release in 1 bottle68180-118-07LupinIndia12 September 2011
500 tablet, extended release in 1 bottle13668-300-05Torrent PharmaceuticalsIndia30 January 2026
120 tablet, extended release in 1 bottle13668-300-12Torrent PharmaceuticalsIndia30 January 2026
250 tablet, extended release in 1 bottle13668-300-25Torrent PharmaceuticalsIndia30 January 2026
60 tablet, extended release in 1 bottle13668-300-60Torrent PharmaceuticalsIndia30 January 2026
500 tablet, film coated, extended release in 1 bottle60505-3517-5Apotex12 September 2011
60 tablet, film coated, extended release in 1 bottle60505-3517-6Apotex12 September 2011
120 tablet, extended release in 1 bottle81665-100-12Omnivium Pharmaceuticals24 October 2022
60 tablet, extended release in 1 bottle81665-100-60Omnivium Pharmaceuticals11 June 2020
500 tablet, film coated, extended release in 1 bottle50228-190-05ScieGen Pharmaceuticals27 November 2020
30 tablet, film coated, extended release in 1 bottle50228-190-30ScieGen Pharmaceuticals27 November 2020
60 tablet, film coated, extended release in 1 bottle50228-190-60ScieGen Pharmaceuticals27 November 2020
60 tablet, film coated, extended release in 1 bottle43547-346-06Solco healthcare1 May 2014
500 tablet, film coated, extended release in 1 bottle43547-346-50Solco healthcare1 May 2014
60 tablet, extended release in 1 bottle68001-114-06BluePoint Laboratories13 February 2014
60 tablet, film coated, extended release in 1 bottle60429-350-60Golden State Medical Supply5 March 2013
100 tablet, film coated, extended release in 1 bottle, plastic71205-881-00Proficient Rx5 November 2021
1000 tablet, film coated, extended release in 1 bottle, plastic71205-881-11Proficient Rx5 November 2021
30 tablet, film coated, extended release in 1 bottle, plastic71205-881-30Proficient Rx5 November 2021
500 tablet, film coated, extended release in 1 bottle, plastic71205-881-55Proficient Rx5 November 2021
60 tablet, film coated, extended release in 1 bottle, plastic71205-881-60Proficient Rx5 November 2021
240 tablet, film coated, extended release in 1 bottle, plastic71205-881-64Proficient Rx5 November 2021
120 tablet, film coated, extended release in 1 bottle, plastic71205-881-72Proficient Rx5 November 2021
180 tablet, film coated, extended release in 1 bottle, plastic71205-881-78Proficient Rx5 November 2021
90 tablet, film coated, extended release in 1 bottle, plastic71205-881-90Proficient Rx5 November 2021
50 pouch in 1 box / 1 tablet, film coated, extended release in 1 pouch70518-4731-0Remedyrepack21 August 2026
60 tablet, film coated, extended release in 1 bottle, plastic69367-333-60Westminster Pharmaceuticals30 September 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 November 1999Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Levetiracetam 750 mg extended-release tablet.

Compare 1

Other strengths and forms of Levetiracetam

Clinical summary

Levetiracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. MedsAcross supplies Levetiracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Levetiracetam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Levetiracetam 750 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.